Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lanboto logo — Pioneering the future of pet medicine through innovation and...

Lanboto

Pioneering the future of pet medicine through innovation and excellence in research, production, sales, and service.

Founded 2017 Series B Total: $100.00M

General Information

Company Name Lanboto
Founded Year 2017
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Lanboto. To contact Lanboto, visit lanboto.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Lanboto

Lanboto is a pioneering animal health firm that is focused on revolutionizing the future of pet medicine through innovation and excellence in research, production, sales, and service. Established in 2017, the company is dedicated to the research and development, production, sales, and servicing of new pet medicines. Lanboto recently secured a significant milestone with a CNY100.00M Series B investment on 13 July 2023, signaling strong investor confidence in the company's vision and potential. The investment was led by InnoMed Capital and Zhuopu Touzi, showcasing the support of prominent and strategic investors in the animal health industry. This funding is poised to fuel Lanboto's continued growth and development, positioning the company as a key player in reshaping the landscape of pet medicine.

Taxonomy: pet medicine, animal health, innovation, excellence, production, sales, service, veterinary medicine, pharmaceuticals, animal care, veterinary services

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY100.00M 2
InnoMed Capital
InnoMed Capital, Zhuopu Touzi
13 Jul 2023
Angel Round Undisclosed -
01 Jan 2018

Lanboto Alternatives & Competitors

Lanboto vs
Scout Bio
Scout Bio United States

Shaping the future of veterinary medicine through one-time therapies for major chronic pet health co...

Series B
11 employees
Biotechnology, Health Care
Lanboto vs
VETSFARMA LIMITED
VETSFARMA LIMITED India

Vetsfarma since 1979.

73 employees
Manufacturing, Pharmaceutical
Lanboto vs
Univet
Univet France

Les vétérinaires unis

Private Equity
489 employees
Health Care, Nutrition

FAQ About Lanboto

Pioneering the future of pet medicine through innovation and excellence in research, production, sales, and service.
Lanboto was founded in 2017.
Lanboto has completed 2 funding rounds, raising a total of $100.00M. The latest funding stage is Series B.
Top alternatives and competitors to Lanboto include Scout Bio, VETSFARMA LIMITED, Univet, GIGI VET, Vestem. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lanboto and Scout Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lanboto, https://bouncewatch.com/company/lanboto, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes